The U.S. Food and Drug Administration (FDA) implemented its Quality Management System Regulation (QMSR) on February 2, 2026, updating the quality system requirements for medical device manufacturers under 21 CFR Part 820.
The QMSR incorporates ISO 13485:2016 by reference, bringing FDA’s quality management requirements into closer alignment with the internationally recognized standard for medical device quality management systems.
For manufacturers supplying medical devices to the U.S. market, including international manufacturers, understanding these changes is important for maintaining an effective quality management system and preparing for FDA inspections.
Why Did FDA Introduce the QMSR?
The QMSR is intended to modernize and harmonize FDA’s medical device quality system requirements with international quality management practices.
The change is designed to:
- Align FDA requirements more closely with ISO 13485:2016
- Reduce differences between U.S. and international quality system requirements
- Provide a more consistent framework for medical device quality management
- Support a risk-based approach to FDA inspections
FDA states that the requirements of ISO 13485 and the former Quality System Regulation are substantially similar when considered as a whole.
What Changed Under the QMSR?
1. Greater Alignment with ISO 13485
The QMSR incorporates ISO 13485:2016 into FDA’s regulatory framework.
For manufacturers already operating an ISO 13485-based quality management system, this alignment may reduce differences between their existing quality processes and FDA requirements. However, ISO 13485 certification by itself does not replace compliance with all applicable FDA requirements.
2. A New FDA Inspection Process
Beginning February 2, 2026, FDA stopped using the previous Quality System Inspection Technique (QSIT) for medical device inspections.
FDA now uses the updated inspection process described in Compliance Program 7382.850, which incorporates the QMSR framework and uses a risk-based approach.
Manufacturers should therefore be prepared to demonstrate how their quality management system meets applicable QMSR requirements and to provide relevant quality records during an inspection.
3. Greater Attention to Quality Records
Under the QMSR, FDA may review a broader range of quality system records during inspections, including management review, quality audit, and supplier audit records.
This makes effective documentation, supplier controls, quality audits, and management oversight important areas for manufacturers to review.
What Should Medical Device Manufacturers Do in 2026?
Manufacturers supplying the U.S. market can consider the following steps:
- Review existing quality management procedures against QMSR requirements
- Compare current procedures with ISO 13485:2016 requirements
- Review risk management and design-and-development processes
- Strengthen supplier qualification and purchasing controls
- Review internal audit and management review procedures
- Train relevant employees on the updated FDA inspection process
- Maintain organized quality records that can demonstrate compliance
What Does QMSR Mean for Global Suppliers?
For international manufacturers and suppliers, the QMSR makes understanding both FDA requirements and ISO 13485 increasingly important when supplying medical devices to the U.S. market.
Companies that already operate an ISO 13485-based quality management system may have a useful foundation for the transition, but they should still review their systems against the specific requirements applicable under U.S. regulations.
For medical device distributors and healthcare procurement organizations, understanding these regulatory developments can also help when evaluating suppliers, quality documentation, and product compliance.
Conclusion
The implementation of QMSR represents an important change in the U.S. medical device quality regulatory framework. As FDA inspections transition to the updated QMSR inspection process, manufacturers and global suppliers should review their quality systems, documentation, risk management, and supplier controls to ensure they are prepared for the requirements applicable to their products.
This article is provided for general informational purposes and is not legal or regulatory advice. Manufacturers should consult the current FDA regulations and applicable regulatory professionals for product-specific compliance requirements.
Sources: U.S. Food and Drug Administration (FDA), Quality Management System Regulation (QMSR).